Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy
{{output}}
T cell receptor (TCR)-based immunotherapy has emerged as a promising therapeutic approach for the treatment of patients with solid cancers. Identifying peptide-human leukocyte antigen (pHLA) complexes highly presented on tumors and rarely expressed on healthy ... ...
